Third Harmonic Bio Statistics
Total Valuation
THRD has a market cap or net worth of $233.31 million. The enterprise value is -$34.62 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
THRD has 45.13 million shares outstanding. The number of shares has increased by 8.23% in one year.
| Current Share Class | 45.13M |
| Shares Outstanding | 45.13M |
| Shares Change (YoY) | +8.23% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 3.09% |
| Owned by Institutions (%) | 40.07% |
| Float | 15.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 54.10, with a Debt / Equity ratio of 0.01.
| Current Ratio | 54.10 |
| Quick Ratio | 53.24 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -19.94% and return on invested capital (ROIC) is -14.80%.
| Return on Equity (ROE) | -19.94% |
| Return on Assets (ROA) | -14.60% |
| Return on Invested Capital (ROIC) | -14.80% |
| Return on Capital Employed (ROCE) | -23.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.01M |
| Employee Count | 53 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.51% in the last 52 weeks. The beta is 2.24, so THRD's price volatility has been higher than the market average.
| Beta (5Y) | 2.24 |
| 52-Week Price Change | -56.51% |
| 50-Day Moving Average | 4.16 |
| 200-Day Moving Average | 9.03 |
| Relative Strength Index (RSI) | 77.62 |
| Average Volume (20 Days) | 1,114,345 |
Short Selling Information
The latest short interest is 1.67 million, so 3.71% of the outstanding shares have been sold short.
| Short Interest | 1.67M |
| Short Previous Month | 1.72M |
| Short % of Shares Out | 3.71% |
| Short % of Float | 10.89% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -64.30M |
| Pretax Income | -32.74M |
| Net Income | -53.45M |
| EBITDA | -64.25M |
| EBIT | -64.30M |
| Earnings Per Share (EPS) | -$1.25 |
Full Income StatementBalance Sheet
The company has $271.61 million in cash and $3.00 million in debt, giving a net cash position of $268.61 million or $5.95 per share.
| Cash & Cash Equivalents | 271.61M |
| Total Debt | 3.00M |
| Net Cash | 268.61M |
| Net Cash Per Share | $5.95 |
| Equity (Book Value) | 272.62M |
| Book Value Per Share | 6.06 |
| Working Capital | 270.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$41.69 million and capital expenditures -$10,000, giving a free cash flow of -$41.70 million.
| Operating Cash Flow | -41.69M |
| Capital Expenditures | -10,000 |
| Free Cash Flow | -41.70M |
| FCF Per Share | -$0.92 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |